Pharmas restart drug trials after pandemic-related declines, Medidata finds

3 weeks ago 2
Pharmaceutical companies have ramped up clinical trials in the past month, rebounding from a steep decline in activity following the start of the coronavirus outbreak, though activity remains below pre-pandemic levels, according to new research shared with Reuters. Read More
Read Original Article